Now accepting Telehealth appointments. Schedule a virtual visit.

IVF after COVID-19: ASRM and SART Release Reopening Guidelines

IVF after COVID-19: ASRM and SART Release Reopening Guidelines

Availability of PPE will be just one part of the reopening considerations for IVF centers that closed to prevent the spread of COVID-19. Image by Jon Tyson via Unsplash.

[This article deals with a continuously developing situation. It was written by Norbert Gleicher, MD, on April 28, 2020 and published on April 29, 2020. For a list of all COVID-19 Bulletins, scroll to the bottom.]

We are very pleased that the _American Society for Reproductive Medicine (ASRM) _and its daughter society, the _Society for Assisted Reproductive Technology (SART) _on April 24 published new guidance for fertility centers that closed their doors during the COVID-19 crisis and, now, are considering resuming patient care. CHR sees this as an important first step in reopening the infrastructure many couples and individuals urgently need in order to be able to access fertility services. We also hope that reopening of some IVF centers will ease the burden on the centers that are still open but have started to refuse monitoring for outside patients due to being "too busy."

Since CHR never closed its doors, most of the recommendations made in this guidance have already been implemented. Some policies that have been in place at CHR over the last few weeks even exceeded measures recommended by ASRM/SART. The guidance, however, also proposed new language for an informed consent for as long as risks of COVID-19 infections persists, and CHR will implement this consent starting this week. We are looking forward to serving our patients in the safest and most effective ways, as we have done over the last few weeks. We are hopeful that we will be able to progressively relax some of the currently still in place restrictions over the coming weeks and months. Please do not hesitate to contact us with any questions you may have, at 212-994-4400 or online.

CHR's COVID-19 Bulletins

Norbert Gleicher, MD

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Follow on LinkedIn    

Watch his videos on YouTube    


We have helped women bring over
17,800 babies into the world.



You Might Also Enjoy...

The Voice June 2022

We are pleased to present here the June issue of the CHR VOICE, after which we traditionally start a two-month summer hiatus for this newsletter, returning to our regular monthly publication schedule with the start of the new 2022-2023...

The Voice May 2022

April was a hectic month at the CHR because the deadline period for abstract submission to the Annual Meeting of the ASRM is always hectic.

The Voice April 2022

March was an unusually busy month at the CHR and not only clinically. CHR’s investigators saw several important papers published, with one in NATURE Medicine, in detail presented in the March issue of the VOICE, receiving unusual media attention

The Voice March 2022

With Spring per schedule knocking on the door, the mood in the world feels anything but spring-like. The deadly and cruel Russian war machine is already for weeks invading the independent country of Ukraine.

The Voice February 2022

In the shortest and traditionally coldest month of the year, we welcome you to the February issue of our monthly newsletter. Hopefully, history will show that we reached a point in the Covid-19 pandemic with more hope than at any time slot before.